FindTrial
Sign In

Clinical trial of exosomes derived from mesenchymal stem cells on the therapy for children with severe infection

Clinical trial of exosomes derived from mesenchymal stem cells on the therapy for children with severe infection

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2100044280
Enrollment
Unknown
Registered
2021-03-14
Start date
2022-01-01
Completion date
Unknown
Last updated
2021-08-30

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

children with severe infection

Interventions

control group:conventional therapy
experimental group:exosomes derived from mesenchymal stem cells

Sponsors

Children's Hospital of Fudan University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
No minimum to 18 Years

Inclusion criteria

Inclusion criteria: 1. Children between 0 and 18 years old; 2. Sepsis. Patients were included who meet the International Guide to the 2020 campaign to Save sepsis: management of septic shock and sepsis-related organ dysfunction in children.

Exclusion criteria

Exclusion criteria: 1. Notifiable infectious diseases; 2. The researcher believes that he is not suitable to participate in other situations in this study; 3. Participants in other clinical trials in the same period.

Design outcomes

Primary

MeasureTime frame
general information;inflammatory factor;Infection-related indicators;Effectiveness evaluation;—

Countries

China

Contacts

Public ContactLu Guoping

Children's Hospital of Fudan University

13788904150@163.com+86 13788904150

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026